Synergistic interactions of repurposed drugs that inhibit Nsp1, a major virulence factor for COVID-19
出版年份 2022 全文链接
标题
Synergistic interactions of repurposed drugs that inhibit Nsp1, a major virulence factor for COVID-19
作者
关键词
-
出版物
Scientific Reports
Volume 12, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-06-17
DOI
10.1038/s41598-022-14194-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2
- (2022) Mohammad Afsar et al. eLife
- Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response
- (2021) Jing-wen Lin et al. Cell Host & Microbe
- SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
- (2021) Constantinos Kurt Wibmer et al. NATURE MEDICINE
- Screening of drug databank against WT and mutant main protease of SARS-CoV-2: Towards finding potential compound for repurposing against COVID-19
- (2021) Tanuj Sharma et al. SAUDI JOURNAL OF BIOLOGICAL SCIENCES
- Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression
- (2021) Ke Zhang et al. Science Advances
- Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries
- (2021) Rui Wang et al. GENOMICS
- SARS-CoV-2 non-structural protein 1 inhibits the interferon response by causing depletion of key host signaling factors.
- (2021) Anil Kumar et al. JOURNAL OF VIROLOGY
- Integrated docking and enhanced sampling-based selection of repurposing drugs for SARS-CoV-2 by targeting host dependent factors
- (2021) Amit Kumawat et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms
- (2021) Christine Vazquez et al. PLoS One
- The total number and mass of SARS-CoV-2 virions
- (2021) Ron Sender et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SARS-CoV-2 infection triggers widespread host mRNA decay leading to an mRNA export block
- (2021) James M. Burke et al. RNA
- SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
- (2021) Matthew McCallum et al. SCIENCE
- Rilpivirine inhibits SARS-CoV-2 protein targets: A potential multi-target drug
- (2021) Fuad Ameen et al. Journal of Infection and Public Health
- Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severity
- (2021) Hin Chu et al. Science Advances
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
- (2021) Einav G. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Topical collection on Chromatin Biology and Epigenetics
- (2020) Geeta Narlikar et al. JOURNAL OF BIOSCIENCES
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- The Architecture of SARS-CoV-2 Transcriptome
- (2020) Dongwan Kim et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- SynergyFinder 2.0: visual analytics of multi-drug combination synergies
- (2020) Aleksandr Ianevski et al. NUCLEIC ACIDS RESEARCH
- Identification of potential drugs against SARS-CoV-2 non-structural protein 1 (nsp1)
- (2020) Gabriela de Lima Menezes et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology
- (2020) Natacha S. Ogando et al. JOURNAL OF GENERAL VIROLOGY
- Montelukast drug activity and potential against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
- (2020) Dennis C. Copertino et al. JOURNAL OF MEDICAL VIROLOGY
- Machine learning classification can reduce false positives in structure-based virtual screening
- (2020) Yusuf O. Adeshina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2
- (2020) Matthias Thoms et al. SCIENCE
- A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes
- (2020) Colin D. Funk et al. Frontiers in Pharmacology
- SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation
- (2020) Katharina Schubert et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2
- (2020) Allan Sauvat et al. Cell Death & Disease
- Evasion of Type I Interferon by SARS-CoV-2
- (2020) Hongjie Xia et al. Cell Reports
- Structure of nonstructural protein 1 from SARS-CoV-2.
- (2020) Lauren K. Clark et al. JOURNAL OF VIROLOGY
- Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA
- (2020) Shuai Yuan et al. MOLECULAR CELL
- Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2
- (2020) Ryan M. Hekman et al. MOLECULAR CELL
- Structural characterization of nonstructural protein 1 from SARS-CoV-2
- (2020) Cameron Semper et al. iScience
- Simple Determination of Plasma Ponatinib Concentration Using HPLC
- (2018) Takeo Yasu et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Ligand-biased ensemble receptor docking (LigBEnD): a hybrid ligand/receptor structure-based approach
- (2017) Polo C.-H. Lam et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- DrugBank 5.0: a major update to the DrugBank database for 2018
- (2017) David S Wishart et al. NUCLEIC ACIDS RESEARCH
- MERS coronavirus nsp1 participates in an efficient propagation through a specific interaction with viral RNA
- (2017) Yutaka Terada et al. VIROLOGY
- Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals
- (2016) Manel Aouri et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ZINC 15 – Ligand Discovery for Everyone
- (2015) Teague Sterling et al. Journal of Chemical Information and Modeling
- Coronavirus nonstructural protein 1: Common and distinct functions in the regulation of host and viral gene expression
- (2015) Krishna Narayanan et al. VIRUS RESEARCH
- Searching for Drug Synergy in Complex Dose–Response Landscapes Using an Interaction Potency Model
- (2015) Bhagwan Yadav et al. Computational and Structural Biotechnology Journal
- Identification of Residues of SARS-CoV nsp1 That Differentially Affect Inhibition of Gene Expression and Antiviral Signaling
- (2013) Andrew R. Jauregui et al. PLoS One
- e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design
- (2012) Emilie Pihan et al. BIOINFORMATICS
- Docking and scoring with ICM: the benchmarking results and strategies for improvement
- (2012) Marco A. C. Neves et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Severe Acute Respiratory Syndrome Coronavirus nsp1 Facilitates Efficient Propagation in Cells through a Specific Translational Shutoff of Host mRNA
- (2012) T. Tanaka et al. JOURNAL OF VIROLOGY
- Structure-based drug screening for G-protein-coupled receptors
- (2012) Brian K. Shoichet et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- SARS Coronavirus nsp1 Protein Induces Template-Dependent Endonucleolytic Cleavage of mRNAs: Viral mRNAs Are Resistant to nsp1-Induced RNA Cleavage
- (2011) Cheng Huang et al. PLoS Pathogens
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now